Penn Capital Management’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-47,649
Closed -$3.13M 210
2020
Q1
$3.13M Sell
47,649
-35,884
-43% -$2.86M 0.52% 72
2019
Q4
$6.83M Sell
83,533
-7,892
-9% -$605K 0.72% 47
2019
Q3
$6.61M Sell
91,425
-14,739
-14% -$1.08M 0.69% 53
2019
Q2
$9.13M Sell
106,164
-4,298
-4% -$349K 0.9% 34
2019
Q1
$8.93M Sell
110,462
-37,301
-25% -$2.79M 0.86% 37
2018
Q4
$10M Sell
147,763
-26,437
-15% -$1.79M 0.99% 30
2018
Q3
$13.8M Sell
174,200
-38,585
-18% -$2.43M 1.05% 24
2018
Q2
$11.2M Sell
212,785
-3,484
-2% -$164K 0.83% 50
2018
Q1
$9.4M Buy
+216,269
New +$9.94M 0.74% 57

Other funds holding OMCL

Penn Capital Management's OMCL Position: Q2 2020 in Review

Penn Capital Management sold out of Omnicell (OMCL) in Q2 2020, closing a stake of 47,649 shares — an estimated $3.13M sold.

Penn Capital Management first reported a position in OMCL in Q1 2018 and held it in 9 quarters. The position peaked at $13.8M in Q3 2018. 295 funds tracked by Wall St. Rank hold OMCL as of Q2 2020.

  • Penn Capital Management reported no remaining Omnicell position as of Q2 2020 after selling out during the quarter.
  • Penn Capital Management sold 47,649 Omnicell shares in Q2 2020, an estimated $3.13M.
  • Penn Capital Management first reported a position in Omnicell in Q1 2018 and held it in 9 quarters.
  • Penn Capital Management's Omnicell position peaked at $13.8M in Q3 2018.
  • 295 funds tracked by Wall St. Rank held Omnicell as of Q2 2020.

Based on Penn Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.